Literature DB >> 22807964

Expression of CD133 in SW620 colorectal cancer cells is modulated by the microenvironment.

Zhili Yang1, Zhigang Wang, Youben Fan, Qi Zheng.   

Abstract

The use of CD133 as a marker for identifying and isolating colon cancer stem cells (CSCs) is controversial. In particular, it is not clear whether the pattern of expression is influenced by the tumor microenvironment. We analysed the expression of CD133 in the SW620 colon cancer cell line, which produces subpopulations with different levels of CD133. CD133(neg) and CD133(hi) SW620 cells were isolated and compared in hanging drop spheroid cultures. The expression of CD133 was examined under different culture conditions and following nutrient withdrawal. The results showed that SW620 cells express the CD133 antigen at variable levels. CD133(neg) and CD133(hi) SW620 cells can be separated by fluorescence-activated cell sorting and, when grown as adherent cells in liquid culture, are serially passaged without changes to the CD133 levels. However, the CD133 antigen is re-expressed when the CD133(neg) cells are deprived of nutrients or grown as non-adherent cells in spheroid cultures. Our observations indicate that the presence of the CD133 antigen does not identify a stem cell population of SW620 colorectal cancer cells. The expression of CD133 is dynamic and is modulated during certain cell culture conditions, suggesting that changes in expression may be mediated by the energy supply available to the cells.

Entities:  

Year:  2012        PMID: 22807964      PMCID: PMC3398359          DOI: 10.3892/ol.2012.694

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  31 in total

1.  Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells.

Authors:  Michael F Clarke; John E Dick; Peter B Dirks; Connie J Eaves; Catriona H M Jamieson; D Leanne Jones; Jane Visvader; Irving L Weissman; Geoffrey M Wahl
Journal:  Cancer Res       Date:  2006-09-21       Impact factor: 12.701

Review 2.  Intercellular communication in spheroids.

Authors:  H Dertinger; D F Hülser
Journal:  Recent Results Cancer Res       Date:  1984

3.  Classification of human colorectal adenocarcinoma cell lines.

Authors:  A Leibovitz; J C Stinson; W B McCombs; C E McCoy; K C Mazur; N D Mabry
Journal:  Cancer Res       Date:  1976-12       Impact factor: 12.701

4.  Identification and characterization of tumorigenic liver cancer stem/progenitor cells.

Authors:  Stephanie Ma; Kwok-Wah Chan; Liang Hu; Terence Kin-Wah Lee; Jana Yim-Hung Wo; Irene Oi-Lin Ng; Bo-Jian Zheng; Xin-Yuan Guan
Journal:  Gastroenterology       Date:  2007-04-15       Impact factor: 22.682

5.  Type I collagen inhibits differentiation and promotes a stem cell-like phenotype in human colorectal carcinoma cells.

Authors:  S C Kirkland
Journal:  Br J Cancer       Date:  2009-06-30       Impact factor: 7.640

6.  The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer.

Authors:  David Horst; Silvio K Scheel; Sibylle Liebmann; Jens Neumann; Susanne Maatz; Thomas Kirchner; Andreas Jung
Journal:  J Pathol       Date:  2009-12       Impact factor: 7.996

Review 7.  CD133: molecule of the moment.

Authors:  D Mizrak; M Brittan; M R Alison
Journal:  J Pathol       Date:  2008-01       Impact factor: 7.996

8.  Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types.

Authors:  Jens M Kelm; Nicholas E Timmins; Catherine J Brown; Martin Fussenegger; Lars K Nielsen
Journal:  Biotechnol Bioeng       Date:  2003-07-20       Impact factor: 4.530

9.  Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4.

Authors:  Matilde Todaro; Mileidys Perez Alea; Anna B Di Stefano; Patrizia Cammareri; Louis Vermeulen; Flora Iovino; Claudio Tripodo; Antonio Russo; Gaspare Gulotta; Jan Paul Medema; Giorgio Stassi
Journal:  Cell Stem Cell       Date:  2007-10-11       Impact factor: 24.633

Review 10.  Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review.

Authors:  P Vaupel; F Kallinowski; P Okunieff
Journal:  Cancer Res       Date:  1989-12-01       Impact factor: 12.701

View more
  8 in total

Review 1.  Stem cells and cancer stem-like cells in endocrine tissues.

Authors:  Ricardo V Lloyd; Heather Hardin; Celina Montemayor-Garcia; Fabio Rotondo; Luis V Syro; Eva Horvath; Kalman Kovacs
Journal:  Endocr Pathol       Date:  2013-03       Impact factor: 3.943

Review 2.  Strategies for isolating and enriching cancer stem cells: well begun is half done.

Authors:  Jiang-Jie Duan; Wen Qiu; Sen-Lin Xu; Bin Wang; Xian-Zong Ye; Yi-Fang Ping; Xia Zhang; Xiu-Wu Bian; Shi-Cang Yu
Journal:  Stem Cells Dev       Date:  2013-05-09       Impact factor: 3.272

Review 3.  CD133: a cancer stem cells marker, is used in colorectal cancers.

Authors:  Fei Ren; Wei-Qi Sheng; Xiang Du
Journal:  World J Gastroenterol       Date:  2013-05-07       Impact factor: 5.742

4.  CD133/prominin-1-mediated autophagy and glucose uptake beneficial for hepatoma cell survival.

Authors:  Haiyang Chen; Zaili Luo; Liwei Dong; Yexiong Tan; Jiamei Yang; Gensheng Feng; Mengchao Wu; Zhong Li; Hongyang Wang
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

5.  Cancer stem cell gene profile as predictor of relapse in high risk stage II and stage III, radically resected colon cancer patients.

Authors:  Riccardo Giampieri; Mario Scartozzi; Cristian Loretelli; Francesco Piva; Alessandra Mandolesi; Giovanni Lezoche; Michela Del Prete; Alessandro Bittoni; Luca Faloppi; Maristella Bianconi; Luca Cecchini; Mario Guerrieri; Italo Bearzi; Stefano Cascinu
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

6.  RNA sequencing and functional studies of patient-derived cells reveal that neurexin-1 and regulators of this pathway are associated with poor outcomes in Ewing sarcoma.

Authors:  Elizabeth Ann Roundhill; Mariona Chicon-Bosch; Lee Jeys; Michael Parry; Kenneth S Rankin; Alastair Droop; Susan Ann Burchill
Journal:  Cell Oncol (Dordr)       Date:  2021-08-17       Impact factor: 6.730

7.  CD133 prevents colon cancer cell death induced by serum deprivation through activation of Akt-mediated protein synthesis and inhibition of apoptosis.

Authors:  Yusuke Mori; Ayaka Takeuchi; Kengo Miyagawa; Hiroyuki Yoda; Hiroaki Soda; Yoshihiro Nabeya; Naoko Watanabe; Toshinori Ozaki; Osamu Shimozato
Journal:  FEBS Open Bio       Date:  2021-03-28       Impact factor: 2.693

8.  Celecoxib-Induced Modulation of Colon Cancer CD133 Expression Occurs through AKT Inhibition and Is Monitored by 89Zr Immuno-PET.

Authors:  Kyung-Ho Jung; Jin Hee Lee; Mina Kim; Eun Ji Lee; Young Seok Cho; Kyung-Han Lee
Journal:  Mol Imaging       Date:  2022-01-07       Impact factor: 4.488

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.